Introduction
Stem cells are a revolutionary breakthrough in modern regenerative medicine because of their ability to regenerate damaged cells and tissues. This ability to differentiate into specific cell lines, such as neurons or heart cells, has offered a renewable source of replacement cells and tissues to treat almost any human disease, such as Alzheimers disease, spinal cord injury, or heart disease.
Stem cells are a revolutionary breakthrough in modern regenerative medicine because of their ability to regenerate damaged cells and tissues. This ability to differentiate into specific cell lines, such as neurons or heart cells, has offered a renewable source of replacement cells and tissues to treat almost any human disease, such as Alzheimers disease, spinal cord, injury or heart disease. Stem cells, however, have also been the spark of huge controversy over the years. Much of the controversy comes from scientists stating that it is impossible to obtain new lines of human embryonic stem cells without destroying human embryos. On one side of the controversy is the potentially great, though unrealized, promise of the stem cell lines to advance knowledge and more importantly, to relieve human suffering. However, on the other side of the controversy is the respect for human life. Although both sides of the argument have something important to defend, the debate continues without consensus among the American population. Stem cell research remains entangled in legal, ethical, and political conflicts. This article will help define the reasons why this issue has been the cause of so much debate and why scientists keep doing stem cell research despite the ethical dilemmas it implies.
WHAT are Stem Cells?
Stem cells are undifferentiated cells found in multicellular organisms. These primary cells are capable of dividing and remain unspecialized for relatively long periods of time. Then, when the necessary signals are present, the process of constant replication, called proliferation, is triggered. Typically, stem cells can yield millions of cells when cultured in laboratories. Nevertheless, the precise signals that are necessary to promote the differentiation process remain largely unknown. Molecules present in the microenvironment, such as chemokines and hormones, and cell-to-cell contact between neighboring cells seem to be the responsible factors that determine how this important biological process is carried out (Stem Cells).
Three safe stem cells sources have been found: five-day embryos, adult organs, and umbilical cords (Types of Stem Cells). However, work is still under way to extract such cells from other unthinkable parts of the human body such as epidermis and bone marrow. Some scientists are developing biological mechanisms to reverse differentiated cells into nave stem cells.
Embryonic Stem Cells
Typically, five-day, pre-implanted embryos called blastocysts are said to be the best source of stem cells. Although alternative sources are known, stem cells from blastocysts have the unique potential to differentiate into all cell lines. Furthermore, blastocysts can be easily cultured in vitro to produce all possible stem cells which are relatively easy to collect, purify, and manage for research purposes (Types of Stem Cells).
Adult Stem Cells
Somatic stem cells or adult stem cells are cells that have undergone partial undergone differentiation, but not to a complete extent. For instance, nerve stem cells can only differentiate into any cells that are found within brain tissues but not into cells that are foreign to the brain such as liver cells. Adult stem cells are only localized within specific organs, especially those that undergo constant cell replacement due to chemical or mechanical exhaustion. The current interest on somatic stem cells involves finding a mechanisms that would allow scientists to reverse the partial differentiation in order to have a totally pluripotent cell line (Types of Stem Cells). Despite the significant progress that has been made, it is clear that further research is still needed.
Umbilical Cord
The umbilical cord connects a developing embryo or fetus to the placenta. It regulates nutrient exchange between mother/offspring. The umbilical cord is composed of three vessels, two arteries, and one vein. Umbilical cord blood is particularly rich in stem cells. Although the more versatile stem cells are derived from embryos, stem cells derived from umbilical cord are capable of forming a relatively decent number of specialized cell types. Moreover, the fact that umbilical cord stem cells can provide an "ethical" alternative to the use of embryos as stem cells sources illustrates their current medical importance (Types of Stem Cells).
Stem Cells and Modern Medicine
Stems cells have been used for over thirty years in the U.S. for cancer patients with leukemia (cancer of the blood or bone marrow) and lymphoma (cancer that originates in a type of white blood cell in the immune system). Treatment of these generally involves a stem cell transplant, usually from stem cells previously removed from the patient or from a matching donor. In the worst case scenario, stem cells can actually be removed from the donors bone marrow right before chemotherapy and are re-injected afterwards. These treatments aim at replacing the donors stem cells, which are damaged by the toxic agents during chemotherapy, with healthy ones. By introducing healthy stem cells, the damaged and destroyed blood producing cells in the patient are replaced. Without this replacement, death is highly possible.
Scientists have also found that the treatment of neurodegenerative diseases can be improved with the use of stem cells. One example is Alzheimers disease. In 1966, Alois Alzheimer described a disease by which brain neurons were progressively destroyed. The ultimate effects of the disease were the loss of memory and distortion in thinking and behavior patterns. Alzheimers disease is the most prevalent form of dementia currently affecting more than 5 million Americans. Thus far, no cure has been found since a reminiscent characteristic of neurons is their inability to divide. Since neuron transplants are virtually impossible, no other treatment to reverse the malignant effects of the disease has been developed. Several drugs have been developed but they can only delay the progressive destruction of tissue in the brain and alleviate temporary symptoms. These drugs cannot reverse the permanent brain damage. Experiments involving adult stem cells, contrastingly, have proven to be capable of not only stopping the adverse effects, but also of reversing the damage already caused. According to an article It is important to note, however, that the usefulness of stem cells goes far beyond the treatment of only Alzheimers or any other form of human neurodegenerative diseases. Its usefulness extends to treating most forms of human cancer and other diseases in which cells have been permanently destroyed. Such diseases include liver failure, renal repair, diabetes, and diverse heart conditions. In theory, stem cells could provide a customized cure to most human diseases, may even provide an alternative to regenerate lost limbs, and substitute plastic surgery as the leading skin regeneration approach.
Why the Controversy?
Because stem cells are obtained from destroyed embryos, the possibility that cell lines could be developed from cloned embryos raises ethical concerns associated with propriety of human cloning. In stem cell research, stem cells can be collected from the cloned embryo and studied in the laboratory. This gives scientists an opportunity to study how stem cells develop and how they can be re-programmed' to develop into different cell types to make replacement tissue. However, stem cell research has brought about much controversy throughout the years. There have been debates over government funding of the research as well as the ethical dilemmas this kind of research entails.
The controversy began in 2001 when President Bush decided to limit federal funding for stem cell research. He also limited the amount of research that can be done to only the 60 existing stem cell lines. Although public funding has allowed the research to continue, scientists argued that the 60 stem cell lines wouldnt be enough to satisfy research needs. Public funding has permitted research to continue with the development of new embryos but scientists are still fighting for government funding. The federal government is the biggest funder of biomedical research. Having government funding would result in more efficient research. Another downside to the lack of government funding is that many scientists from the United States have gone to the United Kingdom to conduct their research since the U.K. has approved both stem cell research and therapeutic cloning.
Stem cell research continues to be at the center of debate as the field of science continues to develop. Medical research often takes many years to be successful and there are many risks and ethical concerns related to stem cell research. However, if a treatment for a disease is found from stem cell research, how will that change the publics perspective on this controversial issue? Will it still be considered unethical?
What Are The Recent Developments in Stem Cell
Research?
There have been many developments in the controversy that surrounds stem cell research. There is constant political pressure to expand the level of governmentfunded stem cell research. Such pressure has truly increased ongoing reports of the medical efficacy of such treatments and the potential they carry. Though Congress has attempted to pass certain legislation authorizing expansions such as these all have been vetoed by President George W. Bush because of religious convictions (News). Of course, the possible medical advancements which might result from stem cell research continue to excite the scientific community. One of the most recent developments that have truly struck interest within the scientific community is the recent progress that is being made in the development of alternatives to the use of embryos. If such a development becomes a reality, it can be said that most political/ethical concerns regarding the matter will be resolved.
Stem cell research continues to be controversial. It was an issue in the 2004 Presidential campaign because of the death of former President Ronald Reagan from Alzheimer's disease. Some of Reagans family members have been vocal advocates of the possible potential of stem cell research to provide treatments for such conditions. Reagans son spoke at the Democratic convention concerning this subject (News). Recent polls show the rising support for such research, especially amongst Republicans. Furthermore, voters in California recently approved a ballot measure to establish a public funded stem cell research program in their state. Much like in 2000, the 2006 Democratic platform continues to support funding for this research. However, due to religious beliefs, support amongst republicans is still sparse (News). There have been many indications that some European and Asian countries have already approved such research.
Stem cell research has contributed to medical developments. There have been two major developments that have captured the attention of both researchers and the public. Recently a ground breaking announcement was made that there was evidence of isolation of pluripotent stem cells which include human embryos. Soon after, there was the first ever recorded cloning of a sheep named Dolly (Hogan) . With such advancements, it is hard to understand why stem cell research is so controversial. Only by understanding what stem cell research really is and its benefits can society actually make a well founded argument against or for such research.
Stem Cell Research and America
Due to stem cell research being a much heated debate in the United States, very few medical treatments are currently available for humans using stem cells. While the U.S. faces great public debate of the ethical issues involved in stem cell research and treatment, many other counties in the world do not. The U.S. advancement of stem cell treatment and research is minor in comparison to other less ethic-dominated counties. For example, China has many stem cell treatments available. While most of these treatments are still in the initial stages, the results so far have been extremely promising. Most Chinese stem cell treatments focus on neurological diseases. Patients suffering for ALS, ataxia, autism, brain injury, cerebral palsy, epilepsy, multiple sclerosis, Parkinsons diseases, spinal cord injury, and stroke have all reported that Chinese stem cell treatment has greatly improved their condition. Most of these treatments involve direct injection of umbilical cord stem cells and rehabilitation therapy. A growing number of Chinese hospitals are now considering the stem cell approach that has been pioneered by such facilities like Tianan Puhun Hospital, Huashan Hospital, Institute of Hematology and National Research Center for Stem Cells, and Beike Biotechnological Company.
This research is very new and most of the treatment of human patients has happened within the last year couple of years. Actual conclusions cannot yet be stated since it is believed that a multiple number of stem cell treatments are needed to fully cure an ailment (if possible). It is still to be known whether Chi-nese stem cell treatment is an actual cure for these diseases or just a procedure given regularly in order to keep the diseases at bay. Overall, stem cell research and treatment is very promising. If America continues to limit stem cell research, it will soon stop being a leading country for medical research and treatment.
Stem Cells in the News
In Brussels on November 20 2001, the big controversy of Human Stem Cell Patents heavily debated by a group on Bioethics Church called the Society Commission. European Churches and its predecessor EECCS have been discussing this issue on behalf of the working group led by Dr. Donald Bruce. This group is composed of specialists and experts from different fields including biochemistry, chemistry, genetics, law, medicine, medical and technological ethics, and practical theology. Moreover, they are from European Protestant and Orthodox churches in Finland, France, Germany, Greece, Italy, Netherlands, Russia, Slovakia, Switzerland, and the UK.
Claims were made stating that these churches were not opposed to the patenting of certain types of biotechnological inventions, but they disputed that the scope of what is considered patentable is too broad. There were many ethical problems to consider. There were misunderstandings as to whether stem cell research should be considered a discovery or an invention, whether stems cells should be considered living or non-living, whether they should be considered genetic material or human body parts, and whether genes should be considered natural products or laboratory made products. The panels concern was that the public would believe that there were inadequate provisions for ethical review of specific patent applications. In addition, they were concerned about the declaration from former president Clinton and Mr. Blair in 2000 which urged against undue commercial control over human genome and the opposition of the French National Ethics commission to the patenting of human genes.
Although stem cell researchs primary goal is to offer a treatment for serious human diseases, some are looking to exploit these developments for commercial purposes. The US allows stem cells "which came from the early human embryo and are pluripotent" to be patented. This means that in the US, all human embryonic stem cells are subject to a monopoly. In Europe, it is argued that human stem cells should not be patented because to grant a patent on any part of the human body (including cells) is for them a violation of Article 21 of the Council of Europes Bioethics convention. This article states, "The human body and its parts shall not, as such, give rise to financial gain." It is also argued that such cells are discoveries and not inventions. Moreover, human stem cells and the body cells derived from them represent something that should not be patented under the Article 6 of Directive98/44/EC. To do so would be contrary to the concept of ordre publique that prohibits a monopoly over what may be proven to be a new way of treating human diseases. It would also violate article 3 of the Council of Europe Bioethics Convention. Furthermore, there are several studies involving stem cells that demonstrate the deterrent effect on research which is caused by granting a variety of new patents in the early developments of new areas of biotechnology.
Stem Cell Research Continues
On November 29, 2007, a new breakthrough in stem cell research was made by scientists from the University of Wisconsin-Madison who first isolated human embryonic stem cells nearly 10 years ago. A team of UW researchers and a group of Japanese scientists have independently been able to reprogram genes in human skin cells to act like embryonic stem cells. If these new cells have all the benefits of embryonic stem cells like the ability to grow into any cell and organ, this research could pave the way for therapies that could overcome the moral and religious objections associated with destroying embryos. Although this breakthrough proves that adult stem cell research has produced promising results, many scientists still think that greater potential is found in embryonic cells. This step forward in adult stem cell research could make embryonic stem cell research obsolete.
Final Remarks
The academic significance of stem cells is far beyond question. Nevertheless, their true significance ultimately lies on the shoulders of society. Research funded by federal and state sources should represent the interests of society. This funding is made possible by governmental institutions such as the National Institutes of Health. The number of scientific, peer-review publications on stem-cells research is enormous. Approximately 15,316 reviews and 152,259 scientific papers related to successful experiments involving stem cells have been published. If stem cells did not offer any real alternative to current medical practices, funding from federal sources (e.g. National Institute of Health, National Science Foundation), state sources (e.g. research grants), and private interests (e.g. Pfizer, Bayer) would be minimal, if not null.
